Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ACUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2008 -1.19M
June 30, 2008 -2.318M
March 31, 2008 -1.314M
December 31, 2007 -2.072M
September 30, 2007 -1.849M
June 30, 2007 14.15M
March 31, 2007 -1.179M
December 31, 2006 22.08M
September 30, 2006 -1.678M
June 30, 2006 37.63M
March 31, 2006 -0.077M
December 31, 2005 1.725M
September 30, 2005 18.21M
June 30, 2005 -0.951M
Date Value
March 31, 2005 50.50M
December 31, 2004 5.750M
September 30, 2004 16.62M
June 30, 2004 0.2152M
March 31, 2004 -0.2074M
December 31, 2003 47.40M
September 30, 2003 -0.1515M
June 30, 2003 16.47M
March 31, 2003 -0.9817M
December 31, 2002 -0.983M
September 30, 2002 -0.943M
June 30, 2002 13.17M
March 31, 2002 -0.4487M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. -4.647M
Corcept Therapeutics, Inc. -2.037M
Veru, Inc. -0.0519M
Johnson & Johnson -8.777B
Eli Lilly & Co. 8.426B